Yuxuan Yang
No. 107, Wenhua Xi Road
Jinan, China
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Unraveling regorafenib resistance: metabolic reprogramming, tumor plasticity, and novel approaches to overcome therapy failure.
Journal: Archives of pharmacal research
Published: December 13, 2025
The Safety and Efficacy of Unilateral Biportal Endoscopic Decompression for the Treatment of Thoracic Ossification of Ligamentum Flavum with Occupancy Ratio > 60%: A Retrospective Cohort Study.
Journal: Pain and therapy
Published: October 22, 2025
Disulfidptosis-related genes define a prognostic signature and novel therapeutic targets in Ewing's sarcoma through transcriptomic analysis and experimental validation.
Journal: Frontiers in immunology
Published: October 11, 2025
Metabolic Syndrome and Low Back Pain: Evidence from Cross-Sectional and Mendelian Randomization Analysis.
Journal: Journal of pain research
Published: September 15, 2025
Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities.
Journal: Molecular biomedicine
Published: August 13, 2025
Flubendazole inhibits cervical carcinoma by targeting DHODH to induce ferroptosis and mitophagy.
Journal: Biochemical pharmacology
Published: April 12, 2025
Navigating Transition Metal-Dependent Cell Death: Mechanisms, Crosstalk, and Future Directions.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 31, 2025
Epigallocatechin-3-gallate suppresses Hepatitis B virus replication through activating the AMPK/TFEB pathway to promote autophagic degradation of viral core protein.
Journal: Chinese journal of natural medicines
Published: January 14, 2025
Fructose-1,6-bisphosphatase 1 in cancer: Dual roles, mechanistic insights, and therapeutic potential - A comprehensive review.
Journal: International journal of biological macromolecules
Published: December 14, 2024
Gene signatures of m5C regulators may predict prognosis and immunity status of patients with Ewing's sarcoma.
Journal: International immunopharmacology
Published: April 19, 2024
Last Updated: 09/26/2026